TY - JOUR
T1 - Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre
AU - Scharlau, Daniel
AU - Borowicki, Anke
AU - Habermann, Nina
AU - Hofmann, Thomas
AU - Klenow, Stefanie
AU - Miene, Claudia
AU - Munjal, Umang
AU - Stein, Katrin
AU - Glei, Michael
N1 - Funding Information:
Work on primary cells was supported by the German Research Council, Deutsche Forschungsgemeinschaft, Germany (DFG PO 284/8-1). The work on LT97 cells was supported by the German Research Council, BMBF, Germany (FKZ 01EA0103) and the work on HT29 cells by ORAFTI, Tienen, Belgium (PRECANTOO). The intervention study with synbiotics was supported by EU (QCRT-1999-00346). Research on prebiotics was supported by the German Research Council, BMBF (FKZ 01EA0503 + PTJ-BIO/0313829C/D’O), Deutsche Forschungsgemeinschaft, Germany (PO 284/8-2), EU project SEAFOODPLUS (FQS-506359) and the Food Standards Agency, Biomics (N 12013). We thank all donors of biopsies and tissue samples for giving their informed consent and supporting the work. In addition we thank Dr. K. Richter (Department of General, Visceral and Vascular Surgery, Friedrich Schiller University of Jena) for supplying samples from tumour resections. We thank Dr. K. Tuohy (Department of Food Microbial Sciences, School of Food Biosciences, University of Reading, United Kingdom) who kindly provided the fermentation supernatants. Additionally, we thank Prof. G. Jahreis (Department of Nutritional Physiology, Institute for Nutrition, Friedrich Schiller University Jena, Germany) for identifying the short-chain fatty acids in the fermentation samples and Prof. B. Marian (Institute for Cancer Research, Medical University of Vienna, Austria) for the kindly gift of LT97 cells.
PY - 2009/7
Y1 - 2009/7
N2 - Dietary fibres are indigestible food ingredients that reach the colon and are then fermented by colonic bacteria, resulting mainly in the formation of short-chain fatty acids (SCFA) such as acetate, propionate, and butyrate. Those SCFA, especially butyrate, are recognised for their potential to act on secondary chemoprevention by slowing growth and activating apoptosis in colon cancer cells. Additionally, SCFA can also act on primary prevention by activation of different drug metabolising enzymes. This can reduce the burden of carcinogens and, therefore, decrease the number of mutations, reducing cancer risk. Activation of GSTs by butyrate has been studied on mRNA, protein, and enzyme activity level by real-time RT-PCR, cDNA microarrays, Western blotting, or photometrical approaches, respectively. Butyrate had differential effects in colon cells of different stages of cancer development. In HT29 tumour cells, e.g., mRNA GSTA4, GSTP1, GSTM2, and GSTT2 were induced. In LT97 adenoma cells, GSTM3, GSTT2, and MGST3 were induced, whereas GSTA2, GSTT2, and catalase (CAT) were elevated in primary colon cells. Colon cells of different stages of carcinogenesis differed in post-transcriptional regulatory mechanisms because butyrate increased protein levels of different GST isoforms and total GST enzyme activity in HT29 cells, whereas in LT97 cells, GST protein levels and activity were slightly reduced. Because butyrate increased histone acetylation and phosphorylation of ERK in HT29 cells, inhibition of histone deacetylases and the influence on MAPK signalling are possible mechanisms of GST activation by butyrate. Functional consequences of this activation include a reduction of DNA damage caused by carcinogens like hydrogen peroxide or 4-hydroxynonenal (HNE) in butyrate-treated colon cells. Treatment of colon cells with the supernatant from an in vitro fermentation of inulin increased GST activity and decreased HNE-induced DNA damage in HT29 cells. Additional animal and human studies are needed to define the exact role of dietary fibre and butyrate in inducing GST activity and reducing the risk of colon cancer.
AB - Dietary fibres are indigestible food ingredients that reach the colon and are then fermented by colonic bacteria, resulting mainly in the formation of short-chain fatty acids (SCFA) such as acetate, propionate, and butyrate. Those SCFA, especially butyrate, are recognised for their potential to act on secondary chemoprevention by slowing growth and activating apoptosis in colon cancer cells. Additionally, SCFA can also act on primary prevention by activation of different drug metabolising enzymes. This can reduce the burden of carcinogens and, therefore, decrease the number of mutations, reducing cancer risk. Activation of GSTs by butyrate has been studied on mRNA, protein, and enzyme activity level by real-time RT-PCR, cDNA microarrays, Western blotting, or photometrical approaches, respectively. Butyrate had differential effects in colon cells of different stages of cancer development. In HT29 tumour cells, e.g., mRNA GSTA4, GSTP1, GSTM2, and GSTT2 were induced. In LT97 adenoma cells, GSTM3, GSTT2, and MGST3 were induced, whereas GSTA2, GSTT2, and catalase (CAT) were elevated in primary colon cells. Colon cells of different stages of carcinogenesis differed in post-transcriptional regulatory mechanisms because butyrate increased protein levels of different GST isoforms and total GST enzyme activity in HT29 cells, whereas in LT97 cells, GST protein levels and activity were slightly reduced. Because butyrate increased histone acetylation and phosphorylation of ERK in HT29 cells, inhibition of histone deacetylases and the influence on MAPK signalling are possible mechanisms of GST activation by butyrate. Functional consequences of this activation include a reduction of DNA damage caused by carcinogens like hydrogen peroxide or 4-hydroxynonenal (HNE) in butyrate-treated colon cells. Treatment of colon cells with the supernatant from an in vitro fermentation of inulin increased GST activity and decreased HNE-induced DNA damage in HT29 cells. Additional animal and human studies are needed to define the exact role of dietary fibre and butyrate in inducing GST activity and reducing the risk of colon cancer.
KW - Butyrate
KW - Chemoprevention
KW - Colorectal cancer
KW - Dietary fibre
KW - Drug metabolising enzymes
KW - Gut fermentation
UR - http://www.scopus.com/inward/record.url?scp=68749119436&partnerID=8YFLogxK
U2 - 10.1016/j.mrrev.2009.04.001
DO - 10.1016/j.mrrev.2009.04.001
M3 - Review article
C2 - 19383551
AN - SCOPUS:68749119436
SN - 1383-5742
VL - 682
SP - 39
EP - 53
JO - Mutation Research - Reviews in Mutation Research
JF - Mutation Research - Reviews in Mutation Research
IS - 1
ER -